U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239895) titled 'Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells' on Nov. 16.
Brief Summary: Bronchiolitis obliterans (BO) is a chronic lung disease which was initiated with injury of the bronchiolar epithelium and resulted in nonuniform luminal obliteration or narrowing. Among children, the most common form of BO is post-infectious BO with a lack of treatment guidelines or standard therapy. In this study, an open, single-armed study is performed to preliminarily evaluate the safety and efficacy of airway basal stem cells on treatment of pediatric BO.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
P...